The Scientist

» pharma and culture

Most Recent

image: Hearing Help

Hearing Help

By | September 1, 2015

For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.  

2 Comments

image: Study: Short Headlines Get More Citations

Study: Short Headlines Get More Citations

By | August 27, 2015

Scientific journals that publish papers with snappier titles accrue more citations per paper, according to a report.

0 Comments

image: Opinion: Making Progress by Slowing Down

Opinion: Making Progress by Slowing Down

By | August 24, 2015

Academic research could be strengthened by thinking more and doing less.

5 Comments

image: Valeant Scoops Sprout for $1 Billion

Valeant Scoops Sprout for $1 Billion

By | August 24, 2015

The Canadian pharmaceutical firm is buying the American drugmaker behind the newly approved “female Viagra.”

0 Comments

image: Legionnaires’ Bacteria at GSK

Legionnaires’ Bacteria at GSK

By | August 14, 2015

GlaxoSmithKline temporarily shuts down a manufacturing plant in North Carolina after Legionella bacteria are detected in two external cooling towers.

0 Comments

image: Book Excerpt from <em>Life on the Edge</em>

Book Excerpt from Life on the Edge

By | August 1, 2015

In Chapter 4, “The quantum beat,” authors Johnjoe McFadden and Jim Al-Khalili rethink Newton’s apple from a quantum-biological perspective.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | August 1, 2015

Gods of the Morning, Hedonic Eating, A Beautiful Question, and Genomic Messages

0 Comments

image: Good Vibrations

Good Vibrations

By | August 1, 2015

Does a delicately orchestrated balance between quantum and classical physics distinguish living from nonliving things?

15 Comments

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech